Cargando…

Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation

Identifying markers for breast cancer is important for both diagnosis and the design of treatment strategies. Recent studies have implicated Paired box 5 (PAX5) as a suppressor in various cancer types, where it is silenced by hypermethylation. However, determining the role of PAX5 in breast cancer r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xia, Huang, Jianbo, Luo, Xinrong, Yang, Dejuan, Yin, Xuedong, Peng, Weiyan, Bi, Can, Ren, Guosheng, Xiang, Tingxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216036/ https://www.ncbi.nlm.nih.gov/pubmed/30416383 http://dx.doi.org/10.7150/ijbs.27599

Ejemplares similares

The tumor suppressor interferon regulatory factor 8 inhibits β-catenin signaling in breast cancers, but is frequently silenced by promoter methylation
por: Luo, Xinrong, et al.
Publicado: (2017)

Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β‐catenin signalling and GADD45G expression
por: Zhao, Lijuan, et al.
Publicado: (2016)

Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer
por: Yin, Xuedong, et al.
Publicado: (2016)

DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer
por: Yin, Xuedong, et al.
Publicado: (2013)

Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling
por: Shao, Qing, et al.
Publicado: (2017)

Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells
por: Xiang, Tingxiu, et al.
Publicado: (2013)

19q13 KRAB zinc-finger protein ZNF471 activates MAPK10/JNK3 signaling but is frequently silenced by promoter CpG methylation in esophageal cancer
por: Sun, Ran, et al.
Publicado: (2020)

The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism
por: Feng, Yixiao, et al.
Publicado: (2018)

DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis
por: Le, Xin, et al.
Publicado: (2020)

Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer
por: Xiao, Yun, et al.
Publicado: (2014)

The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
por: Xiang, Tingxiu, et al.
Publicado: (2012)

The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer
por: Shao, Bianfei, et al.
Publicado: (2017)

Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer
por: Tan, Yiqing, et al.
Publicado: (2021)

The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling
por: Zhang, Chong, et al.
Publicado: (2018)

DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells
por: Xiang, Tingxiu, et al.
Publicado: (2016)

Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression
por: Yang, Dejuan, et al.
Publicado: (2018)

Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
por: Li, Yunhai, et al.
Publicado: (2019)

KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer
por: Pei, Lijiao, et al.
Publicado: (2018)

Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer
por: Mu, Junhao, et al.
Publicado: (2017)

The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest
por: Zhang, Yan, et al.
Publicado: (2018)

Interferon Signaling Is Frequently Downregulated in Melanoma
por: Alavi, Sara, et al.
Publicado: (2018)

The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers
por: Li, Yunhai, et al.
Publicado: (2016)

Clinicopathological Characteristics and Breast Cancer–Specific Survival of Patients With Single Hormone Receptor–Positive Breast Cancer
por: Li, Yunhai, et al.
Publicado: (2020)

Forkhead Box L1 Is Frequently Downregulated in Gallbladder Cancer and Inhibits Cell Growth through Apoptosis Induction by Mitochondrial Dysfunction
por: Qin, Yiyu, et al.
Publicado: (2014)

TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
por: Fan, Jiangxia, et al.
Publicado: (2018)

Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Li, Yunhai, et al.
Publicado: (2021)

DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer
por: Jia, Nan, et al.
Publicado: (2016)

Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis
por: Ye, Lin, et al.
Publicado: (2019)

Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer
por: Yuan, Hongfan, et al.
Publicado: (2019)

Rare and Frequent Promoter Methylation, Respectively, of TSHZ2 and 3 Genes That Are Both Downregulated in Expression in Breast and Prostate Cancers
por: Yamamoto, Miyako, et al.
Publicado: (2011)

Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin
por: Pu, Chunyun, et al.
Publicado: (2020)

Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma
por: Pfister, Stefan, et al.
Publicado: (2007)

Box C/D snoRNP catalysed methylation is aided by additional pre-rRNA base-pairing
por: van Nues, Robert Willem, et al.
Publicado: (2011)

Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer
por: Li, Yunhai, et al.
Publicado: (2018)

PCDH18 is frequently inactivated by promoter methylation in colorectal cancer
por: Zhou, Dan, et al.
Publicado: (2017)

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer
por: Wang, Long, et al.
Publicado: (2021)

Association of paired box 6 with high myopia in Japanese
por: Miyake, Masahiro, et al.
Publicado: (2012)

Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
por: Park, S-W, et al.
Publicado: (2004)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer
por: Deng, Jingyu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tmva597qp5cbp3dqq0egd1i1v2